Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity (V6)
Phase II Trial of Daily Dose of Oral Vaccine Against Atherosclerosis
Sponsor: Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare
This PHASE3 trial investigates Atherosclerosis and is currently ongoing. Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
May 2019 — Sep 2020 [monthly]
Recruiting PHASE3
▶ Show 5 earlier versions
-
Sep 2018 — May 2019 [monthly]
Recruiting PHASE3
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE3
-
Jul 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Apr 2017 — Jul 2017 [monthly]
Recruiting PHASE3
Status: Active Not Recruiting → Recruiting
-
Feb 2017 — Apr 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare
- Immunitor LLC
For direct contact, visit the study record on ClinicalTrials.gov .